Sees revenue $715M-$735M, consensus $710.23M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGEN:
- RGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Netflix downgraded, Intel initiated: Wall Street’s top analyst calls
- Repligen resumed with an Overweight at Stephens
- Repligen initiated with an Overweight at Barclays
- Regeneron Stock (REGN) Retreats as Lung Disease Drug Data Disappoints